2-Mercaptoethane sulfonate prevents doxorubicin-induced plasma protein oxidation and TNF-α release: Implications for the reactive oxygen species-mediated mechanisms of chemobrain

Free Radical Biology and Medicine

Volumn 50, Issue 11, 2011, Pages 1630-1638

  Aluise, Christopher D ^a   Miriyala, Sumitra ^a   Noel, Teresa ^a   Sultana, Rukhsana ^a   Jungsuwadee, Paiboon ^a   Taylor, Tamara J ^b   Cai, Jian ^c   Pierce, William M ^c   Vore, Mary ^a   Moscow, Jeffrey A ^b   St Clair, Daret K ^a   Butterfield, D Allan ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

2 Mercaptoethane sulfonate; Adriamycin; Apolipoprotein A1; Chemobrain; Doxorubicin; Free radicals; Inflammation; MESNA; Oxidative stress; Plasma; TNF

Indexed keywords

4 HYDROXYNONENAL; APOLIPOPROTEIN A1; BIOLOGICAL MARKER; DICHLOROFLUORESCEIN; DOXORUBICIN; FREE RADICAL; INTERLEUKIN 10; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MESNA; MONOCYTE CHEMOTACTIC PROTEIN; PLASMA PROTEIN; REACTIVE OXYGEN METABOLITE; SCAVENGER; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CELL STIMULATION; CHEMOBRAIN; COGNITIVE DEFECT; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG COMPETITION; DRUG INDUCED DISEASE; DRUG MECHANISM; HUMAN; INFLAMMATION; MACROPHAGE; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CARBONYLATION; PROTEOMICS; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIOXIDANTS; APOLIPOPROTEIN A-I; CELLS, CULTURED; DOXORUBICIN; HUMANS; MACROPHAGES; MALE; MESNA; MICE; MICE, INBRED STRAINS; NEOPLASMS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEOMICS; REACTIVE OXYGEN SPECIES; TUMOR NECROSIS FACTOR-ALPHA;

MURINAE; MUS;

EID: 79955574686     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2011.03.009     Document Type: Article

References (44)

1. J. Cummings, L. Anderson, N. Willmott, and J.F. Smyth The molecular pharmacology of doxorubicin in vivo Eur. J. Cancer 27 1991 532 535
2. F.A. Fornari, J.K. Randolph, J.C. Yalowich, M.K. Ritke, and D.A. Gewirtz Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells Mol. Pharmacol. 45 1994 649 656 (Pubitemid 24139191)
3. M. Tanaka, and S. Yoshida Mechanism of the inhibition of calf thymus DNA polymerases alpha and beta by daunomycin and adriamycin J. Biochem. 87 1980 911 918 (Pubitemid 10119686)
4. R.Y. Chuang, and L.F. Chuang Inhibition of chicken myeloblastosis RNA polymerase II activity by adriamycin Biochemistry 18 1979 2069 2073 (Pubitemid 9173560)
5. N.R. Bachur, S.L. Gordon, and M.V. Gee Anthracycline antibiotic augmentation of microsomal electron transport and free radical formation Mol. Pharmacol. 13 1977 901 910 (Pubitemid 8188631)
6. P. Deres, R. Halmosi, A. Toth, K. Kovacs, A. Palfi, T. Habon, L. Czopf, T. Kalai, K. Hideg, B. Sumegi, and K. Toth Prevention of doxorubicin-induced acute cardiotoxicity by an experimental antioxidant compound J. Cardiovasc. Pharmacol. 45 2005 36 43 (Pubitemid 40039753)
7. K. Handa, and S. Sato Generation of free radicals of quinone group-containing anti-cancer chemicals in NADPH-microsome system as evidenced by initiation of sulfite oxidation Gann 66 1975 43 47
8. J.M. Gutteridge Lipid peroxidation and possible hydroxyl radical formation stimulated by the self-reduction of a doxorubicin-iron(III) complex Biochem. Pharmacol. 33 1984 1725 1728 (Pubitemid 14109436)
9. Y. Chen, C. Daosukho, W.O. Opii, D.M. Turner, W.M. Pierce, J.B. Klein, M. Vore, D.A. Butterfield, and D.K. St Clair Redox proteomic identification of oxidized cardiac proteins in adriamycin-treated mice Free Radic. Biol. Med. 41 2006 1470 1477 (Pubitemid 44466730)
10. S.M. DeAtley, M.Y. Aksenov, M.V. Aksenova, B. Jordan, J.M. Carney, and D.A. Butterfield Adriamycin-induced changes of creatine kinase activity in vivo and in cardiomyocyte culture Toxicology 134 1999 51 62 (Pubitemid 29243776)
11. P. Jungsuwadee, M.P. Cole, R. Sultana, G. Joshi, J. Tangpong, D.A. Butterfield, D.K. St Clair, and M. Vore Increase in Mrp1 expression and 4-hydroxy-2-nonenal adduction in heart tissue of adriamycin-treated C57BL/6 mice Mol. Cancer Ther. 5 2006 2851 2860 (Pubitemid 44849012)
12. C.D. Aluise, D. St Clair, M. Vore, and D.A. Butterfield In vivo amelioration of adriamycin induced oxidative stress in plasma by gamma-glutamylcysteine ethyl ester (GCEE) Cancer Lett. 282 2009 25 29
13. E. Fadillioglu, and H. Erdogan Effects of erdosteine treatment against doxorubicin-induced toxicity through erythrocyte and plasma oxidant/antioxidant status in rats Pharmacol. Res. 47 2003 317 322 (Pubitemid 36315754)
14. J.R. Munoz-Castaneda, J. Muntane, M.C. Munoz, I. Bujalance, P. Montilla, and I. Tunez Estradiol and catecholestrogens protect against adriamycin-induced oxidative stress in erythrocytes of ovariectomized rats Toxicol. Lett. 160 2006 196 203 (Pubitemid 41628106)
15. H. Alkreathy, Z.A. Damanhouri, N. Ahmed, M. Slevin, S.S. Ali, and A.M. Osman Aged garlic extract protects against doxorubicin-induced cardiotoxicity in rats Food Chem. Toxicol. 48 2010 951 956
16. P. Montilla, I. Tunez, M.C. Munoz, A. Lopez, and J.V. Soria Hyperlipidemic nephropathy induced by adriamycin: effect of melatonin administration Nephron 76 1997 345 350 (Pubitemid 27296539)
17. W.S. Thayer Evaluation of tissue indicators of oxidative stress in rats treated chronically with adriamycin Biochem. Pharmacol. 37 1988 2189 2194
18. M. Yagmurca, H. Erdogan, M. Iraz, A. Songur, M. Ucar, and E. Fadillioglu Caffeic acid phenethyl ester as a protective agent against doxorubicin nephrotoxicity in rats Clin. Chim. Acta 348 2004 27 34 (Pubitemid 39208997)
19. A.I. Othman, M.A. El-Missiry, M.A. Amer, and M. Arafa Melatonin controls oxidative stress and modulates iron, ferritin, and transferrin levels in adriamycin treated rats Life Sci. 83 2008 563 568
20. Y.C. Yeh, T.J. Liu, L.C. Wang, H.W. Lee, C.T. Ting, W.L. Lee, C.J. Hung, K.Y. Wang, and H.C. Lai A standardized extract of Ginkgo biloba suppresses doxorubicin-induced oxidative stress and p53-mediated mitochondrial apoptosis in rat testes Br. J. Pharmacol. 156 2009 48 61
21. X.J. Qin, W. He, C.X. Hai, X. Liang, and R. Liu Protection of multiple antioxidants Chinese herbal medicine on the oxidative stress induced by adriamycin chemotherapy J. Appl. Toxicol. 28 2008 271 282 (Pubitemid 351518114)
22. R. Injac, M. Boskovic, M. Perse, E. Koprivec-Furlan, A. Cerar, A. Djordjevic, and B. Strukelj Acute doxorubicin nephrotoxicity in rats with malignant neoplasm can be successfully treated with fullerenol C60(OH)24 via suppression of oxidative stress Pharmacol. Rep. 60 2008 742 749
23. J. Tangpong, M.P. Cole, R. Sultana, G. Joshi, S. Estus, M. Vore, W. St Clair, S. Ratanachaiyavong, D.K. St Clair, and D.A. Butterfield Adriamycin-induced, TNF-alpha-mediated central nervous system toxicity Neurobiol. Dis. 23 2006 127 139 (Pubitemid 44192385)
24. J. Tangpong, M.P. Cole, R. Sultana, S. Estus, M. Vore, W. St Clair, S. Ratanachaiyavong, D.K. St Clair, and D.A. Butterfield Adriamycin-mediated nitration of manganese superoxide dismutase in the central nervous system: insight into the mechanism of chemobrain J. Neurochem. 100 2007 191 201 (Pubitemid 46090774)
25. G. Joshi, C.D. Aluise, M.P. Cole, R. Sultana, W.M. Pierce, M. Vore, D.K. St Clair, and D.A. Butterfield Alterations in brain antioxidant enzymes and redox proteomic identification of oxidized brain proteins induced by the anti-cancer drug adriamycin: implications for oxidative stress-mediated chemobrain Neuroscience 166 2010 796 807
26. L. Bruton, B. Chabner, and B. Knollman Goodman & Gilman's The Pharmacological Basis of Therapeutics 2010 12th Edition, McGraw-Hill Medical, New York
27. S.C. Piscitelli, K.A. Rodvold, D.A. Rushing, and D.A. Tewksbury Pharmacokinetics and pharmacodynamics of doxorubicin in patients with small cell lung cancer Clin. Pharmacol. Ther. 53 1993 555 561 (Pubitemid 23161203)
28. E.J. Freireich, E.A. Gehan, D.P. Rall, L.H. Schmidt, and H.E. Skipper Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man Cancer Chemother. Rep. 50 1966 219 244
29. J. Drake, J. Kanski, S. Varadarajan, M. Tsoras, and D.A. Butterfield Elevation of brain glutathione by gamma-glutamylcysteine ethyl ester protects against peroxynitrite-induced oxidative stress J. Neurosci. Res. 68 2002 776 784 (Pubitemid 34594994)
30. V. Thongboonkerd, J. Luengpailin, J. Cao, W.M. Pierce, J. Cai, J.B. Klein, and R.J. Doyle Fluoride exposure attenuates expression of Streptococcus pyogenes virulence factors J. Biol. Chem. 277 2002 16599 16605 (Pubitemid 34967677)
31. E.G. Gutierrez, W.A. Banks, and A.J. Kastin Murine tumor necrosis factor alpha is transported from blood to brain in the mouse J. Neuroimmunol. 47 1993 169 176 (Pubitemid 23284281)
32. B. Osburg, C. Peiser, D. Domling, L. Schomburg, Y.T. Ko, K. Voigt, and U. Bickel Effect of endotoxin on expression of TNF receptors and transport of TNF-alpha at the blood-brain barrier of the rat Am. J. Physiol. Endocrinol. Metab. 283 2002 E899 E908
33. D.A. Butterfield, H.F. Poon, D. St Clair, J.N. Keller, W.M. Pierce, J.B. Klein, and W.R. Markesbery Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease Neurobiol. Dis. 22 2006 223 232
34. R. Sultana, D. Boyd-Kimball, H.F. Poon, J. Cai, W.M. Pierce, J.B. Klein, W.R. Markesbery, X.Z. Zhou, K.P. Lu, and D.A. Butterfield Oxidative modification and down-regulation of Pin1 in Alzheimer's disease hippocampus: a redox proteomics analysis Neurobiol. Aging 27 2006 918 925
35. N. Hyka, J.M. Dayer, C. Modoux, T. Kohno, C.K. Edwards III, P. Roux-Lombard, and D. Burger Apolipoprotein A-I inhibits the production of interleukin-1beta and tumor necrosis factor-alpha by blocking contact-mediated activation of monocytes by T lymphocytes Blood 97 2001 2381 2389 (Pubitemid 32291485)
36. H.E. Mohamed, M.E. Asker, S.I. Ali, and T.M. el-Fattah Protection against doxorubicin cardiomyopathy in rats: role of phosphodiesterase inhibitors type 4 J. Pharm. Pharmacol. 56 2004 757 768 (Pubitemid 38801692)
37. P.R. Deepa, and P. Varalakshmi Influence of a low-molecular-weight heparin derivative on the nitric oxide levels and apoptotic DNA damage in adriamycin-induced cardiac and renal toxicity Toxicology 217 2006 176 183 (Pubitemid 41773833)
38. J. Tangpong, P. Sompol, M. Vore, W. St Clair, D.A. Butterfield, and D.K. St Clair Tumor necrosis factor alpha-mediated nitric oxide production enhances manganese superoxide dismutase nitration and mitochondrial dysfunction in primary neurons: an insight into the role of glial cells Neuroscience 151 2008 622 629
39. R.B. Raffa, and R.J. Tallarida Chemo-Fog 2010 Landis Biosci. Press Austin
40. D.A. Butterfield, and E.R. Stadtman Protein oxidation processes in aging brain Adv. Cell Aging Gerontol. 2 1997 161 191
41. B. Gressier, N. Lebegue, C. Brunet, M. Luyckx, T. Dine, M. Cazin, and J.C. Cazin Scavenging of reactive oxygen species by letosteine, a molecule with two blocked -SH groups: comparison with free -SH drugs Pharm. World Sci. 17 1995 76 80
42. N. Brock, P. Hilgard, J. Pohl, K. Ormstad, and S. Orrenius Pharmacokinetics and mechanism of action of detoxifying low-molecular-weight thiols J. Cancer Res. Clin. Oncol. 108 1984 87 97 (Pubitemid 14095230)
43. M.E. Szapacs, H.Y. Kim, N.A. Porter, and D.C. Liebler Identification of proteins adducted by lipid peroxidation products in plasma and modifications of apolipoprotein A1 with a novel biotinylated phospholipid probe J. Proteome Res. 7 2008 4237 4246
44. R.J. Bernacki, S.K. Bansal, and H.L. Gurtoo Combinations of MESNA with cyclophosphamide or adriamycin in the treatment of mice with tumors Cancer Res. 47 1987 799 802 (Pubitemid 17027976)